Neonatal abstinence syndrome and intra-uterine growth restriction secondary to maternal antimigraine drug abuse

Basic Clin Pharmacol Toxicol. 2021 Apr;128(4):625-627. doi: 10.1111/bcpt.13514. Epub 2020 Oct 21.
No abstract available

Keywords: butalbital; caffeine; chronic pain; intra-uterine growth restriction; neonatal abstinence syndrome.

Publication types

  • Case Reports

MeSH terms

  • Aminopyrine / adverse effects*
  • Barbiturates / adverse effects*
  • Caffeine / adverse effects*
  • Drug Combinations
  • Female
  • Fetal Growth Retardation / diagnosis*
  • Fetal Growth Retardation / etiology
  • Humans
  • Infant, Newborn
  • Male
  • Maternal Exposure / adverse effects*
  • Neonatal Abstinence Syndrome / diagnosis*
  • Neonatal Abstinence Syndrome / etiology
  • Substance-Related Disorders / complications*

Substances

  • Barbiturates
  • Drug Combinations
  • Aminopyrine
  • Caffeine
  • optalidon